Skip to content
Top Globe News – Lifestyle
Author:
Expression Therapeutics, Inc.
Expression Therapeutics Awarded NCI SBIR Grant to Advance ET501, a PTK7-Targeted γδ T-Cell Therapy for Children with High-Risk Neuroblastoma
October 15, 2026